Literature DB >> 9726533

Protection of human upper respiratory tract cell lines against sulphur mustard toxicity by hexamethylenetetramine (HMT).

D J Andrew1, C D Lindsay.   

Abstract

1. Sulphur mustard ('mustard gas', HD) is a highly toxic chemical warfare agent which affects the skin and respiratory tract. The primary targets of inhaled HD are the epithelia of the upper respiratory tract. Hexamethylenetetramine (HMT) has been shown to protect human lung cells against HD toxicity and has also been shown to be effective in vivo against the chemical warfare agent phosgene. The ability of HMT to protect against the toxicity of HD was investigated in the human upper respiratory tract cell lines BEAS-2B and RPMI 2650. 2. HD was highly toxic to both cell lines, with LC50 values of 15-30 microM. HMT, at a concentration of 10 mM, was shown to protect the cell lines against the toxic effects of 20 microM and 40 microM HD. Results demonstrated that it was necessary for HMT to be in situ at the time of exposure to HD for effective cytoprotection. No protection was seen when cells were treated with HMT following exposure to HD, or where HMT was removed prior to HD exposure. 3. Results suggest that HMT may be effective prophylaxis for exposure to HD by inhalation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726533     DOI: 10.1177/096032719801700703

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  2 in total

1.  Myocardial perfusion abnormalities in chemical warfare patients intoxicated with mustard gas.

Authors:  Ali Gholamrezanezhad; Mohsen Saghari; Arsalan Vakili; Sahar Mirpour; Mohammad Hossein Farahani
Journal:  Int J Cardiovasc Imaging       Date:  2006-09-14       Impact factor: 2.357

2.  Screening of the chemoprotective effect of 13 compounds and their mixtures with sodium 2-mercaptoethanesulfonate against 2-chloroethyl ethyl sulfide.

Authors:  Petr Jost; Jaroslav Pejchal; Tomas Kucera; Lubica Muckova; Rudolf Stetina
Journal:  J Appl Biomed       Date:  2019-06-17       Impact factor: 1.797

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.